Several clinical trials are currently being coordinated by physicians at Institut Curie. They cover fields from immunotherapy to development of new targeted therapies (SHIVA02) and radiotherapy, to innovations such as nanoparticles activated by radiotherapy.
Find out more about completed clinical trials:
SCANDARE: Prospective Biobanking Study aiming at Better Understand the Link between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response
CT DNA R0